CD96 as a Potential Immune Regulator in Cancers

被引：13

作者：

Feng, Shikai ^{[1
]}

Isayev, Orkhan ^{[2
]}

Werner, Jens ^{[1
,3
,4
]}

Bazhin, Alexandr V. ^{[1
,3
,4
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Dept Gen Visceral & Transplant Surg, D-81377 Munich, Germany

[2] Azerbaijan Med Univ, Dept Cytol Embryol & Histol, AZ-1022 Baku, Azerbaijan

[3] German Canc Consortium DKTK, Partner Site Munich, D-81377 Munich, Germany

[4] Bavarian Canc Res Ctr BZKF, D-91054 Erlangen, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 02期

关键词：

CD96; CD155; CD226; immune checkpoint molecules; immune modulation; TIGIT; CELL-ADHESION; MOLECULAR-CLONING; RECEPTOR; TIGIT; POLIOVIRUS; CD226; ACTIVATION; EXPRESSION; INTERFACE; TACTILE;

D O I：

10.3390/ijms24021303

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The discovery of CTLA-4 and PD-1 checkpoints has prompted scientific researchers and the pharmaceutical industry to develop and conduct extensive research on tumor-specific inhibitors. As a result, the list of potential immune checkpoint molecules is growing over time. Receptors for nectin and nectin-like proteins have recently emerged as promising targets for cancer immunotherapy. Potential immune checkpoints, including CD226, TIGIT, and CD96, belong to this receptor class. Among them, CD96 has received little attention. In this mini-review, we aim to discuss the basic biology of CD96 as well as the most recent relevant research on this as a promising candidate for cancer immunotherapy.

引用

页数：12

共 50 条

[31] CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
Aguilera, Amelia Roman
Lutzky, Viviana P.
Mittal, Deepak
Li, Xian-Yang
Stannard, Kimberley
Takeda, Kazuyoshi
Bernhardt, Guenter
Teng, Michele W. L.
Dougall, William C.
Smyth, Mark J.
ONCOIMMUNOLOGY, 2018, 7 (05):
[32] Direct interaction between CD155 and CD96 promotes immunosuppression in lung adenocarcinoma
Zhang, Hui
Liu, Qianwen
Lei, Yiyan
Zhou, Jianwen
Jiang, Wenting
Cui, Yongmei
He, Qiong
Zhu, Junfeng
Zhu, Zheng
Sun, Yu
Ke, Zunfu
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (06) : 1575 - 1577
[33] CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer
Song, Xin
Tang, Tao
Li, Chaofeng
Liu, Xin
Zhou, Lei
MEDICAL SCIENCE MONITOR, 2018, 24 : 7820 - 7827
[34] Prognostic Significance of CD96 and CD123 in Adult Acute Myeloid Leukemia Patients in Egypt
Hegab, Hany Mohamed Abdallah
Ibrahim, Rasha Ibrahim
Saeed, Alia Mohammed
Abd Elmonem, Minerva Muhammad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S211 - S211
[35] Targeting of acute myeloid leukemia initiating cells with Fc optimized CD96 antibodies
Staudinger, M.
Peipp, M.
Kellner, C.
Bulduk, M.
Humpe, A.
Gramatzki, M.
Oncology Research and Treatment, 2015, 38 : 8 - 8
[36] CD96 correlates to human NK cell exhaustion and predicts the prognosis of HCC patients
Sun, Cheng
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 348 - 349
[37] Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer
Xu, Chang
Fang, Hanji
Gu, Yun
Yu, Kuan
Wang, Jieti
Lin, Chao
Zhang, Heng
Li, He
He, Hongyong
Liu, Hao
Li, Ruochen
CANCER SCIENCE, 2022, 113 (12) : 4070 - 4081
[38] Effect of blocking CD96 on CD8+T cell-mediated elimination of tumor dormancy
Wang, Hongye
Geng, Haigang
Wu, Zhaorong
Zhong, Yiqing
Song, Zhenyu
Bian, Linke
Cui, Dan
Zhai, Bo
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[39] Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
Peng, Yun-Peng
Xi, Chun-Hua
Zhu, Yi
Yin, Ling-Di
Wei, Ji-Shu
Zhang, Jing-Jing
Liu, Xin-Chun
Guo, Song
Fu, Yue
Miao, Yi
ONCOTARGET, 2016, 7 (41) : 66586 - 66594
[40] The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J Chan
Ludovic Martinet
Susan Gilfillan
Fernando Souza-Fonseca-Guimaraes
Melvyn T Chow
Liam Town
David S Ritchie
Marco Colonna
Daniel M Andrews
Mark J Smyth
Nature Immunology, 2014, 15 : 431 - 438

← 1 2 3 4 5 →